NCT04150159 is a NA clinical trial of FMD Arm in Coronary Artery Disease, sponsored by Hypertension Institute, Nashville.

Who is sponsoring NCT04150159?

NCT04150159 is sponsored by Hypertension Institute, Nashville.

What drugs are being tested in NCT04150159?

Interventions in NCT04150159: FMD Arm.

What condition does NCT04150159 study?

NCT04150159 studies Coronary Artery Disease.

Is NCT04150159 still recruiting?

NCT04150159 is currently completed. Last updated 31 July 2020.

Last reviewed 2020-07-31 · How we verify

NCT04150159

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Fasting Mimicking Diet

Completed NA Last updated 31 July 2020

What this trial tests

NA trial testing FMD Arm in Coronary Artery Disease in 80 participants. Completed in 31 January 2020.

Timeline

1 March 2019

Primary endpoint
31 January 2020

31 January 2020

Quick facts

Lead sponsor	Hypertension Institute, Nashville
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	80
Start date	1 March 2019
Primary completion	31 January 2020
Estimated completion	31 January 2020
Sites	1 location across United States

Drugs / interventions tested

FMD Arm

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Hypertension Institute, Nashville

Who can join

Adults 35 to 75, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, open-label, 7-month trial in eighty (80) adult subjects. Forty (40) subjects will be randomized to the intervention FMD arm with a 5 day meal program every month for four (4) months. Forty subjects will be randomized to a follow a Mediterranean diet plan for four months. Both arms will have a final study visit at month 7.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk.
Brandhorst S, Levine ME, Wei M, Shelehchi M, et al · · 2024 · cited 34× · PMID 38378685 · DOI 10.1038/s41467-024-45260-9
Guts for Self-Eating: Role of Autophagy in Gastrointestinal Health and Disease.
Nighot P, Stine J, Clarke K. · · 2025 · cited 2× · PMID 40487273 · DOI 10.1016/j.gastha.2025.100654
Fasting mimicking diet cycles versus a Mediterranean diet and cardiometabolic risk in overweight and obese hypertensive subjects: a randomized clinical trial.
Mishra A, Fanti M, Ge X, Vaughn D, et al · · 2023 · cited 1× · PMID 40604264 · DOI 10.1038/s44324-023-00002-1

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Hypertension Institute, Nashville trials

Trials by the same sponsor.

NCT03895749 — Effect of a Nitric Oxide Supplementation Product on Endothelial Dysfunction and Prehypertensive Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04150159 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hypertension Institute, Nashville
Last refreshed: 31 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04150159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing